New schizophrenia drug may improve patient compliance

A new pipeline drug, RBP-7000, developed by Indivior for the treatment of schizophrenia, has the potential to improve patient compliance, according to research performed by consulting firm GlobalData. more

24 Mar 2017 12:18 News